title: Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis.
authors.affiliation: Laboratory of Molecular Oncology, Clinic and Policlinic of Oncology, University Hospital of Zürich, Häldeliweg 4, 8044 Zürich, Switzerland.
authors.forename: Roy
authors.initials: R
authors.lastname: Sidi
authors.forename: Giulia
authors.initials: G
authors.lastname: Pasello
authors.forename: Isabelle
authors.initials: I
authors.lastname: Opitz
authors.forename: Alex
authors.initials: A
authors.lastname: Soltermann
authors.forename: Michaela
authors.initials: M
authors.lastname: Tutic
authors.forename: Hubert
authors.initials: H
authors.lastname: Rehrauer
authors.forename: Walter
authors.initials: W
authors.lastname: Weder
authors.forename: Rolf A
authors.initials: RA
authors.lastname: Stahel
authors.forename: Emanuela
authors.initials: E
authors.lastname: Felley-Bosco
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D014408:Biomarkers, Tumor / Q000378:metabolism; D017024:Chemotherapy, Adjuvant; D004249:DNA Damage / Q000187:drug effects; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy* / Q000378:metabolism; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D010997:Pleural Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D017395:Plasminogen Activator Inhibitor 1; C051321:SERPINE1 protein, human